Trius Therapeutics IPO Plans Back on Track  
7/22/2010 7:36:06 AM

Xconomy -- San Diego’s Trius Therapeutics, which was forced to postpone its planned IPO earlier this year to accommodate new FDA guidelines, appears to be back on track. The biotech amended its IPO filing with the Securities and Exchange Commission earlier this week, and the company’s stock offering is now on the runway and scheduled for the week of July 26, according to Renaissance Capital’s IPO calendar.